ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
(2021) Journal of Crohn’s & colitis — Vol. 15, n° 6, p. 879-913 (2021)
Files
KucharzikTJCrohnsColitis2021.pdf
Open Access - Adobe PDF
- 1.45 MB
Details
- Authors
- Abstract
- (en) INTRODUCTION : The introduction and broad use of new immunosuppressive agents, including biologic agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease [IBD] in recent decades. With such immunosuppression, the potential for opportunistic infection is a key safety concern. [...]
- Affiliations
Citations
Kucharzik, T., Ellul, P., Greuter, T., Rahier, J.-F., Verstockt, B., Abreu, C., Albuquerque, A., Alloca, M., Esteve, M., Farraye, F. A., Gordon, H., Karmiris, K., Kopylov, U., Kirchgesner, J., MacMahon, E., Magro, F., Maaser, C., de Ridder, L., Taxonera, C., et al. (2021). ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn’s & colitis, 15(6), 879-913. https://doi.org/10.1093/ecco-jcc/jjab052 (Original work published 2021)